# Protagonist Therapeutics, Inc. (PTGX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PTGX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 269.84M | $ 166.63M | $ 169.73M | $ 9.22M | $ 841.54M |
| 2025 | $ 47.12M | $ -133.26M | $ 59.05M | $ 10.32M | $ 614.71M |
| 2024 | $ 456.62M | $ 289.24M | $ 192.13M | $ 10.87M | $ 675.30M |
| 2023 | $ 64.88M | $ -85.37M | $ -76.60M | $ 1.14M | $ 336.68M |
| 2022 | $ 29.69M | $ -142.31M | $ -121.69M | $ 3.66M | $ 215.61M |
| 2021 | $ 32.52M | $ -149.24M | $ -129.52M | $ 5.86M | $ 300.02M |
| 2020 | $ 36.47M | $ -84.27M | $ -92.94M | $ 5.96M | $ 279.61M |
| 2019 | $ 298.2K | $ -99.63M | $ -54.85M | $ 17.01M | $ 79.96M |
| 2018 | $ 40.84M | $ -51.41M | $ -66.61M | $ 0 | $ -140.47M |
| 2017 | $ 27.03M | $ -49.79M | $ 4.32M | $ 0 | $ -101.55M |
| 2016 | $ 0 | $ -51.15M | $ -41.76M | $ 0 | $ -64.59M |
| 2015 | $ 0 | $ -20.86M | $ -20.76M | $ 0 | $ 9.60M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.05 |
| Current Ratio | 21.71 |

## Other views

- [Metrics](https://sponda.capital/en/PTGX.md)
- [Charts](https://sponda.capital/en/PTGX/charts.md)
- [Compare](https://sponda.capital/en/PTGX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.